AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DUKEMOUNT CAPITAL PLC

Regulatory Filings Aug 22, 2025

4974_rns_2025-08-22_59098dc8-1fa1-49e9-9bdb-04236c90b473.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4501W

capAI PLC

22 August 2025

22 August 2025

A blue brain with lines AI-generated content may be incorrect.

capAI plc

("capAI" or the "Company")

Author42 Beta Deployment and R42 Demo Day

capAI (LSE: CPAI) is pleased to confirm that, further to its announcement of 7 July 2025, the Company's flagship platform www.author42.com will be formally deployed in Beta today.

The Beta will be offered on a subscription basis, with a 7-day free trial available for new users. The initial release is focused on non-fiction works, with expansion to fiction titles planned in due course, alongside the launch of a dedicated online bookstore for Author42 publications.

The platform will be formally launched during the R42 Demo Day, which commences at 16 :00 UK time today. Game42 will be previewed at 16:15, followed by Movie42 at 16:40, with Author42 scheduled to be presented at 18:45 UK time.

The Demo Day is open to all and can be attended online via the following registration link:

https://us02web.zoom.us/meeting/register/_iKFMZS1SHe4lMPQOk8GvA#/registration

Enquiries

Company:

capAI plc [email protected]

Broker Enquiries:

Peterhouse Capital Limited Tel: +44 (0) 207 469 0930

A purple and blue background with white text AI-generated content may be incorrect.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAPTMLTMTJTMLA

Talk to a Data Expert

Have a question? We'll get back to you promptly.